WhiteGlove Health, Inc., a leading chronic care and population health management provider, announced the acquisition of Glenridge HealthCare Solutions, a premier provider of technology-enabled network development and consulting services. WhiteGlove is a portfolio company of Enhanced Equity Funds and Biomark Capital.
Founded in 1997 by the company's President Terry Spoleti and headquartered in Columbia, MD, Glenridge offers a full suite of differentiated services utilizing proprietary tools and software that enable customers to outsource their mission-critical managed care network development and provider engagement needs. Glenridge is focused on creating reform-driven payor strategies and provider alliances and serves national and regional health plans and health systems in all fifty states.
"The acquisition of Glenridge strengthens WhiteGlove's position as a key partner for payors as they continue to adapt to the new healthcare environment," said Nicholas A. Balog, CEO of WhiteGlove. "WhiteGlove's care management tools and value-based care product are highly synergistic with Glenridge's service offering. The combination of these two leading and innovative businesses will help payors and providers improve patient care while containing costs. We are thrilled that Terry will continue to serve as Chief Innovation Officer to help us continue to grow the combined company."
Ms. Spoleti, said, "We are proud of the company we have built and are excited by the vision of the combined business. By combining our two companies we are better situated to help our clients improve patient access to care, improve the quality of existing networks, and manage costs."